Ads
related to: is belimumab approved for lupus patients to take medication for pain control- Learn About Lupus
Discover Symptoms, Triggers, & How
Lupus Affects The Immune System.
- See A Treatment Option
Learn More About A Treatment Option
For Lupus & Discover How It Works.
- See Possible Side Effects
See Possible Side Effects For A
Lupus Nephritis Treatment Option.
- Causes Of Lupus Nephritis
Visit To Learn More About The
Causes Of Lupus Nephritis Today.
- Hear Real Patient Stories
Listen To Patients Talk About Their
Experience With Taking A Treatment.
- Coverage & Co-Pay Info
See If You're Eligible To Save On
Treatment & Find Coverage Info.
- Learn About Lupus
Search results
Results From The WOW.Com Content Network
Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. [8] Sales rose to $31.2 million in the first quarter of 2012. [37] The total cost for the first year of treatment with belimumab is $28,000. [38]
It is given intravenously to cSLE patients with active disease but should not be given to cSLE patients who have active neuropsychiatric cSLE, acute, severe systemic lupus erythematosus disease, or are taking prednisone at doses greater that 1.5 mg per kg per day. Patients taking belimumab have an increased susceptibility to infections. [65]
Hydroxychloroquine was approved by the FDA for lupus in 1955. [120] Some drugs approved for other diseases are used for SLE 'off-label'. In November 2010, an FDA advisory panel recommended approving belimumab (Benlysta) as a treatment for the pain and flare-ups common in lupus. The drug was approved by the FDA in March 2011. [121] [122]
The drug is being tested in patients with the most common form of lupus, systemic lupus erythematosus, where the patient's immune system attacks the body's own tissues and potentially leads to ...
Treatment consists primarily of immunosuppressive drugs (e.g., hydroxychloroquine and corticosteroids). A second-line drug is methotrexate in its low-dose schedule. [18] [19] In 2011, the U.S. Food and Drug Administration (FDA) approved the first new drug for lupus in more than 50 years to be used in the US, belimumab. [20]
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Ads
related to: is belimumab approved for lupus patients to take medication for pain control